$PFE
PFIZER INC

2024 Q2 Form 10-Q Financial Statement

#000007800324000107 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q2
Revenue $13.28B $14.88B $18.28B
YoY Change -27.34% -18.62% -28.76%
Cost Of Revenue $2.768B $3.036B $4.886B
YoY Change -43.35% -39.58% -51.06%
Gross Profit $10.52B $11.84B $13.40B
YoY Change -21.51% -10.67% -14.55%
Gross Profit Margin 79.16% 79.59% 73.27%
Selling, General & Admin $3.668B $3.454B $3.418B
YoY Change 7.31% -0.89% 31.82%
% of Gross Profit 34.88% 29.17% 25.52%
Research & Development $2.696B $2.493B $2.505B
YoY Change 7.62% -1.31% 8.87%
% of Gross Profit 25.64% 21.05% 18.7%
Depreciation & Amortization $1.307B $1.308B $1.487B
YoY Change -12.1% 18.59% 25.27%
% of Gross Profit 12.43% 11.05% 11.1%
Operating Expenses $7.475B $7.101B $5.923B
YoY Change 26.2% 11.84% 21.03%
Operating Profit $3.040B $4.741B $7.473B
YoY Change -59.32% -31.37% -30.7%
Interest Expense -$876.0M -$663.0M $318.0M
YoY Change -375.47% 26.53% -1.24%
% of Operating Profit -28.82% -13.98% 4.26%
Other Income/Expense, Net $1.000M -$1.000M -$70.00M
YoY Change -101.43% -80.0%
Pretax Income -$103.0M $3.421B $6.270B
YoY Change -101.64% -45.44% -30.72%
Income Tax -$134.0M $293.0M $715.0M
% Of Pretax Income 8.56% 11.4%
Net Earnings $41.00M $3.115B $5.543B
YoY Change -99.26% -43.8% -29.51%
Net Earnings / Revenue 0.31% 20.94% 30.32%
Basic Earnings Per Share $0.01 $0.55 $0.98
Diluted Earnings Per Share $0.00 $0.55 $0.97
COMMON SHARES
Basic Shares Outstanding 5.667B shares 5.647B shares 5.634B shares
Diluted Shares Outstanding 5.696B shares 5.697B shares 5.727B shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.453B $8.936B $18.28B
YoY Change -70.18% -7.69%
Cash & Equivalents $1.052B $719.0M $2.166B
Short-Term Investments $4.401B $8.217B $16.12B
Other Short-Term Assets $4.190B $4.372B $5.120B
YoY Change -18.16% 21.85%
Inventory $11.45B $10.89B $9.541B
Prepaid Expenses
Receivables $11.39B $10.99B $12.31B
Other Receivables $3.694B $4.233B $0.00
Total Short-Term Assets $37.83B $42.42B $50.08B
YoY Change -24.47% -7.98%
LONG-TERM ASSETS
Property, Plant & Equipment $18.96B $18.80B $17.05B
YoY Change 11.17% 12.86%
Goodwill $68.45B $69.30B $51.48B
YoY Change 32.96% 2.52%
Intangibles $61.24B $62.83B $42.00B
YoY Change 45.8% 40.87%
Long-Term Investments $8.029B $8.123B $11.18B
YoY Change -28.15% -30.13%
Other Assets $10.71B $11.20B $12.97B
YoY Change -17.39% 64.55%
Total Long-Term Assets $178.2B $178.6B $145.9B
YoY Change 22.1% 12.61%
TOTAL ASSETS
Total Short-Term Assets $37.83B $42.42B $50.08B
Total Long-Term Assets $178.2B $178.6B $145.9B
Total Assets $216.0B $221.0B $196.0B
YoY Change 10.2% 6.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.106B $5.591B $6.123B
YoY Change -16.61% 11.21%
Accrued Expenses $2.566B $2.192B $2.277B
YoY Change 12.69% 1.24%
Deferred Revenue $2.528B $2.502B $1.750B
YoY Change 44.46% -43.69%
Short-Term Debt $8.199B $7.231B $621.0M
YoY Change 1220.29% 61.3%
Long-Term Debt Due $3.745B $1.001B $3.567B
YoY Change 4.99% 1271.92%
Total Short-Term Liabilities $43.82B $40.50B $36.56B
YoY Change 19.85% -6.89%
LONG-TERM LIABILITIES
Long-Term Debt $57.51B $61.31B $31.70B
YoY Change 81.38% -11.08%
Other Long-Term Liabilities $16.10B $15.12B $13.01B
YoY Change 23.72% 23.8%
Total Long-Term Liabilities $73.60B $76.43B $44.71B
YoY Change 64.61% -3.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $43.82B $40.50B $36.56B
Total Long-Term Liabilities $73.60B $76.43B $44.71B
Total Liabilities $128.2B $128.5B $94.38B
YoY Change 35.85% -6.7%
SHAREHOLDERS EQUITY
Retained Earnings $116.6B $121.3B $131.1B
YoY Change -11.06% 17.9%
Common Stock $480.0M $480.0M $478.0M
YoY Change 0.42% 0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost) $114.8B $114.5B
YoY Change 0.48%
Treasury Stock Shares
Shareholders Equity $87.70B $92.28B $101.0B
YoY Change
Total Liabilities & Shareholders Equity $216.2B $221.1B $195.6B
YoY Change 10.52% 6.41%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income $41.00M $3.115B $5.543B
YoY Change -99.26% -43.8% -29.51%
Depreciation, Depletion And Amortization $1.307B $1.308B $1.487B
YoY Change -12.1% 18.59% 25.27%
Cash From Operating Activities -$1.780B $1.090B $1.212B
YoY Change -246.86% -81.47%
INVESTING ACTIVITIES
Capital Expenditures $637.0M $704.0M $1.139B
YoY Change -44.07% 77.14%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $5.237B $0.00 $18.00M
YoY Change 28994.44% 38.46%
Cash From Investing Activities $4.600B $1.732B $3.315B
YoY Change 38.76% 484.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $1.250B $269.0M
YoY Change -83.28%
Cash From Financing Activities -2.459B -$4.931B -$2.771B
YoY Change -11.26% -57.87%
NET CHANGE
Cash From Operating Activities -1.780B $1.090B $1.212B
Cash From Investing Activities 4.600B $1.732B $3.315B
Cash From Financing Activities -2.459B -$4.931B -$2.771B
Net Change In Cash 361.0M -$2.137B $1.754B
YoY Change -79.42% 231.57%
FREE CASH FLOW
Cash From Operating Activities -$1.780B $1.090B $1.212B
Capital Expenditures $637.0M $704.0M $1.139B
Free Cash Flow -$2.417B $386.0M $73.00M
YoY Change -3410.96% -98.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3495000000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3418000000 usd
CY2024Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2493000000 usd
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2505000000 usd
CY2024Q1 us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
2172000000 usd
CY2023Q2 us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
2060000000 usd
CY2024Q1 us-gaap Revenues
Revenues
14879000000 usd
CY2023Q2 us-gaap Revenues
Revenues
18486000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3379000000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4886000000 usd
CY2024Q1 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
CY2023Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
21000000 usd
CY2024Q1 pfe Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
1308000000 usd
CY2023Q2 pfe Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
1103000000 usd
CY2024Q1 pfe Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
102000000 usd
CY2023Q2 pfe Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
9000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-680000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-275000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3421000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6270000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
293000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
715000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3128000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
5555000000 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-5000000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
3123000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5556000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
13000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
3115000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5543000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.55
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.98
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.55
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.97
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5657000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5634000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5697000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5727000000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
3123000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5556000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
140000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
101000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
217000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
2000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
12000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-303000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
205000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
305000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-51000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
87000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
14000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
509000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-65000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-422000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
-28000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
-30000000 usd
CY2024Q1 pfe Other Comprehensive Income Loss Curtailment Adjustmentfrom Aoci Pensionand Other Postretirement Benefit Plansfor Net Prior Service Cost Creditbefore Tax
OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax
0 usd
CY2023Q2 pfe Other Comprehensive Income Loss Curtailment Adjustmentfrom Aoci Pensionand Other Postretirement Benefit Plansfor Net Prior Service Cost Creditbefore Tax
OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax
-5000000 usd
CY2024Q1 us-gaap Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Prior Service Cost Credit Before Tax
DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
28000000 usd
CY2023Q2 us-gaap Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Prior Service Cost Credit Before Tax
DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
35000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
251000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-50000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
53000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-63000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
198000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3321000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5569000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
10000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3319000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5558000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
719000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2853000000 usd
CY2024Q1 us-gaap Other Short Term Investments
OtherShortTermInvestments
11209000000 usd
CY2023Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
9837000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
479000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
470000000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10989000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11566000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
10892000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
10189000000 usd
CY2024Q1 pfe Other Tax Assets Current
OtherTaxAssetsCurrent
4233000000 usd
CY2023Q4 pfe Other Tax Assets Current
OtherTaxAssetsCurrent
3978000000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
4372000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4911000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
42415000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
43333000000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
8123000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
11637000000 usd
CY2024Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
3490000000 usd
CY2023Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
3731000000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16362000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16045000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18803000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18940000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62829000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
64900000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
69297000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
67783000000 usd
CY2024Q1 pfe Deferred Tax Assets Net And Other Tax Assets Noncurrent
DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent
4942000000 usd
CY2023Q4 pfe Deferred Tax Assets Net And Other Tax Assets Noncurrent
DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent
3706000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11197000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12471000000 usd
CY2024Q1 us-gaap Assets
Assets
221095000000 usd
CY2023Q4 us-gaap Assets
Assets
226501000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1001000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2254000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
8232000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
10350000000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5591000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6710000000 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
2372000000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3192000000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2349000000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2192000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2776000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2502000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2700000000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18788000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20537000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
40497000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47794000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61307000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61538000000 usd
CY2024Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
2076000000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
2167000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
931000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
640000000 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
8603000000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
8534000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15122000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16539000000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
128537000000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
137213000000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
480000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
478000000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92997000000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92631000000 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
114755000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
114487000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
121318000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
118353000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7758000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7961000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
92282000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
89014000000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
276000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
274000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
92558000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
89288000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221095000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
226501000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
89288000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
3123000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
198000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-51000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
92558000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
95916000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5556000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-249000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101236000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
3123000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5556000000 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-5000000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3128000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
5555000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1736000000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1487000000 usd
CY2024Q1 pfe Asset Write Offs And Asset Impairment Charges
AssetWriteOffsAndAssetImpairmentCharges
136000000 usd
CY2023Q2 pfe Asset Write Offs And Asset Impairment Charges
AssetWriteOffsAndAssetImpairmentCharges
270000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-441000000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-598000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
220000000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
105000000 usd
CY2024Q1 pfe Pension And Other Postretirement Benefit Contributions Net Of Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense
201000000 usd
CY2023Q2 pfe Pension And Other Postretirement Benefit Contributions Net Of Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense
200000000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
151000000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-99000000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
3336000000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
5507000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1090000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1212000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
704000000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1139000000 usd
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
797000000 usd
CY2023Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6665000000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
658000000 usd
CY2023Q2 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
6400000000 usd
CY2024Q1 pfe Payments For Proceeds From Short Term Investments With Original Maturities Of Three Months Or Less
PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess
1187000000 usd
CY2023Q2 pfe Payments For Proceeds From Short Term Investments With Original Maturities Of Three Months Or Less
PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess
-4665000000 usd
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
35000000 usd
CY2023Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
51000000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collection Of Longterm Investments
ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments
305000000 usd
CY2023Q2 us-gaap Proceeds From Sale Maturity And Collection Of Longterm Investments
ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments
124000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
3491000000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
18000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1732000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3315000000 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1444000000 usd
CY2023Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
11000000 usd
CY2024Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
328000000 usd
CY2023Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-2039000000 usd
CY2023Q2 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
226000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1250000000 usd
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
269000000 usd
CY2024Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
2372000000 usd
CY2023Q2 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
2303000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-386000000 usd
CY2023Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-436000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4931000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2771000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-28000000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2137000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1754000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2917000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
468000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
780000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2222000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
184000000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
329000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
415000000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
419000000 usd
CY2024Q1 pfe Interest Paid Received Interest Rate Hedges
InterestPaidReceivedInterestRateHedges
33000000 usd
CY2023Q2 pfe Interest Paid Received Interest Rate Hedges
InterestPaidReceivedInterestRateHedges
60000000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 operatingsegment
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made certain reclassification adjustments to conform prior-period amounts to the current presentation for: </span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">in the first quarter of 2024, we reclassified royalty income (substantially all of which is related to Biopharma) from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (income)/deductions––net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and began presenting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a separate line item within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of income, and reclassified the associated royalty receivables from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, less allowance for doubtful accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheet; </span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">in the fourth quarter of 2023, we began presenting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alliance revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as separate line items within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of income; and</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">segment reporting and geographic information in connection with the commercial reorganization that went into effect on January 1, 2024 (see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0cab93a3ad074dba9695ef6944702bf7_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business development activities, including the December 2023 acquisition of Seagen, impacted financial results in the periods presented. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0cab93a3ad074dba9695ef6944702bf7_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below, as well as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes 1A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our 2023 Form 10-K.</span></div>
CY2024Q1 pfe Rebates And Other Sales Related Accruals
RebatesAndOtherSalesRelatedAccruals
8481000000 usd
CY2023Q4 pfe Rebates And Other Sales Related Accruals
RebatesAndOtherSalesRelatedAccruals
9014000000 usd
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
-29000000 usd
CY2023Q2 us-gaap Severance Costs1
SeveranceCosts1
-36000000 usd
CY2024Q1 pfe Restructuring Asset Impairment Charges
RestructuringAssetImpairmentCharges
25000000 usd
CY2023Q2 pfe Restructuring Asset Impairment Charges
RestructuringAssetImpairmentCharges
-10000000 usd
CY2024Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
14000000 usd
CY2023Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
2000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
10000000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
-44000000 usd
CY2024Q1 pfe Business Combination Acquisition Related Costs Transaction Costs
BusinessCombinationAcquisitionRelatedCostsTransactionCosts
5000000 usd
CY2023Q2 pfe Business Combination Acquisition Related Costs Transaction Costs
BusinessCombinationAcquisitionRelatedCostsTransactionCosts
0 usd
CY2024Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
87000000 usd
CY2023Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
52000000 usd
CY2024Q1 pfe Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
102000000 usd
CY2023Q2 pfe Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
9000000 usd
CY2024Q1 pfe Implementation Costs
ImplementationCosts
58000000 usd
CY2023Q2 pfe Implementation Costs
ImplementationCosts
85000000 usd
CY2024Q1 pfe Restructuring Charges Acquisition Related Costsand Implementation Costs
RestructuringChargesAcquisitionRelatedCostsandImplementationCosts
168000000 usd
CY2023Q2 pfe Restructuring Charges Acquisition Related Costsand Implementation Costs
RestructuringChargesAcquisitionRelatedCostsandImplementationCosts
107000000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
1988000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
10000000 usd
CY2024Q1 pfe Paymentsfor Restructuring Other Restructuring And Restructuring Translation Adjustment
PaymentsforRestructuringOtherRestructuringAndRestructuringTranslationAdjustment
360000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
1638000000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
129000000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
177000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
790000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
318000000 usd
CY2024Q1 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-661000000 usd
CY2023Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-141000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
25000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-451000000 usd
CY2024Q1 pfe Income Loss From Collaborations Licensing Agreements And Sales Of Compound Product Rights
IncomeLossFromCollaborationsLicensingAgreementsAndSalesOfCompoundProductRights
0 usd
CY2023Q2 pfe Income Loss From Collaborations Licensing Agreements And Sales Of Compound Product Rights
IncomeLossFromCollaborationsLicensingAgreementsAndSalesOfCompoundProductRights
68000000 usd
CY2024Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-103000000 usd
CY2023Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-80000000 usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-208000000 usd
CY2023Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-36000000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
109000000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
264000000 usd
CY2024Q1 pfe Income Loss From Equity Method Investments Net Excess Basis Amortization
IncomeLossFromEquityMethodInvestmentsNetExcessBasisAmortization
-88000000 usd
CY2023Q2 pfe Income Loss From Equity Method Investments Net Excess Basis Amortization
IncomeLossFromEquityMethodInvestmentsNetExcessBasisAmortization
68000000 usd
CY2024Q1 pfe Other Nonoperating Income Expense Net
OtherNonoperatingIncomeExpenseNet
258000000 usd
CY2023Q2 pfe Other Nonoperating Income Expense Net
OtherNonoperatingIncomeExpenseNet
403000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-680000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-275000000 usd
CY2024Q1 us-gaap Other Short Term Investments
OtherShortTermInvestments
11209000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.086
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.114
CY2024Q1 us-gaap Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability
TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability
15000000000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3100000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
25000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-25000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
45000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
3000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
4000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
-21000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
41000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
24000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-6000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
11000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
2000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
64000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-8000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-53000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
-5000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
-7000000 usd
CY2024Q1 pfe Other Comprehensive Income Loss Curtailment Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax
OtherComprehensiveIncomeLossCurtailmentAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
0 usd
CY2023Q2 pfe Other Comprehensive Income Loss Curtailment Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax
OtherComprehensiveIncomeLossCurtailmentAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
-1000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Benefit Plan Improvement Tax Effect
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
5000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Benefit Plan Improvement Tax Effect
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
9000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
53000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-63000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2483000000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5124000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
8217000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
4400000000 usd
CY2024Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
510000000 usd
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
313000000 usd
CY2023Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
9837000000 usd
CY2024Q1 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
2543000000 usd
CY2023Q4 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
2779000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
137000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
150000000 usd
CY2024Q1 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
45000000 usd
CY2023Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
47000000 usd
CY2024Q1 pfe Private Equity Investments
PrivateEquityInvestments
765000000 usd
CY2023Q4 pfe Private Equity Investments
PrivateEquityInvestments
755000000 usd
CY2024Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
3490000000 usd
CY2023Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
3731000000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
8123000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
11637000000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
11613000000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
15368000000 usd
CY2024Q1 pfe Held To Maturity Cash Equivalents
HeldToMaturityCashEquivalents
250000000 usd
CY2023Q4 pfe Held To Maturity Cash Equivalents
HeldToMaturityCashEquivalents
207000000 usd
CY2024Q1 pfe Debt Securities Amortized Cost Basis
DebtSecuritiesAmortizedCostBasis
9234000000 usd
CY2024Q1 pfe Debt Securities Accumulated Gross Unrealized Gain
DebtSecuritiesAccumulatedGrossUnrealizedGain
2000000 usd
CY2024Q1 pfe Debt Securities Accumulated Gross Unrealized Loss
DebtSecuritiesAccumulatedGrossUnrealizedLoss
78000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale And Held To Maturity
DebtSecuritiesAvailableForSaleAndHeldToMaturity
9159000000 usd
CY2024Q1 pfe Debt Securities Maturities Next Twelve Months Fair Value
DebtSecuritiesMaturitiesNextTwelveMonthsFairValue
8976000000 usd
CY2024Q1 pfe Debt Securities Maturities Year Two Through Five Fair Value
DebtSecuritiesMaturitiesYearTwoThroughFiveFairValue
168000000 usd
CY2024Q1 pfe Debt Securities Maturities After Year Five Fair Value
DebtSecuritiesMaturitiesAfterYearFiveFairValue
14000000 usd
CY2023Q4 pfe Debt Securities Amortized Cost Basis
DebtSecuritiesAmortizedCostBasis
5126000000 usd
CY2023Q4 pfe Debt Securities Accumulated Gross Unrealized Gain
DebtSecuritiesAccumulatedGrossUnrealizedGain
6000000 usd
CY2023Q4 pfe Debt Securities Accumulated Gross Unrealized Loss
DebtSecuritiesAccumulatedGrossUnrealizedLoss
16000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale And Held To Maturity
DebtSecuritiesAvailableForSaleAndHeldToMaturity
5115000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
25000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-451000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
214000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
33000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-188000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-485000000 usd
CY2024Q1 pfe Equity Securities Without Readily Determinable Fair Value Impairment Loss And Downward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAndDownwardPriceAdjustmentCumulativeAmount
293000000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
212000000 usd
CY2024Q1 us-gaap Commercial Paper
CommercialPaper
6933000000 usd
CY2023Q4 us-gaap Commercial Paper
CommercialPaper
7965000000 usd
CY2024Q1 pfe Longterm Debt Current Maturities Excluding Net Fair Value Adjustments Related To Hedging And Purchase Accounting
LongtermDebtCurrentMaturitiesExcludingNetFairValueAdjustmentsRelatedToHedgingAndPurchaseAccounting
1000000000 usd
CY2023Q4 pfe Longterm Debt Current Maturities Excluding Net Fair Value Adjustments Related To Hedging And Purchase Accounting
LongtermDebtCurrentMaturitiesExcludingNetFairValueAdjustmentsRelatedToHedgingAndPurchaseAccounting
2250000000 usd
CY2024Q1 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
362000000 usd
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
252000000 usd
CY2024Q1 pfe Shortterm Debt Gross
ShorttermDebtGross
8294000000 usd
CY2023Q4 pfe Shortterm Debt Gross
ShorttermDebtGross
10467000000 usd
CY2024Q1 pfe Debt Instrument Fair Value Adjustments Hedgingand Purchase Accounting
DebtInstrumentFairValueAdjustmentsHedgingandPurchaseAccounting
1000000 usd
CY2023Q4 pfe Debt Instrument Fair Value Adjustments Hedgingand Purchase Accounting
DebtInstrumentFairValueAdjustmentsHedgingandPurchaseAccounting
5000000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
64000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
121000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
8232000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
10350000000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
781000000 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
1146000000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
700000000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1420000000 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
55000000 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
17000000 usd
CY2024Q1 pfe Other Comprehensive Income Loss Non Derivatives And Derivatives Gain Lossbefore Reclassificationand Tax
OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossbeforeReclassificationandTax
490000000 usd
CY2023Q2 pfe Other Comprehensive Income Loss Non Derivatives And Derivatives Gain Lossbefore Reclassificationand Tax
OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossbeforeReclassificationandTax
-160000000 usd
CY2024Q1 pfe Other Comprehensive Income Loss Non Derivatives And Derivatives Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossReclassificationBeforeTax
49000000 usd
CY2023Q2 pfe Other Comprehensive Income Loss Non Derivatives And Derivatives Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossReclassificationBeforeTax
-269000000 usd
CY2024Q1 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
658000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
791000000 usd
CY2024Q1 us-gaap Hedged Liability Fair Value Hedge
HedgedLiabilityFairValueHedge
7186000000 usd
CY2024Q1 us-gaap Hedged Liability Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
-320000000 usd
CY2024Q1 us-gaap Hedged Liability Discontinued Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityDiscontinuedFairValueHedgeCumulativeIncreaseDecrease
941000000 usd
CY2023Q4 us-gaap Hedged Liability Fair Value Hedge
HedgedLiabilityFairValueHedge
7196000000 usd
CY2023Q4 us-gaap Hedged Liability Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
-131000000 usd
CY2023Q4 us-gaap Hedged Liability Discontinued Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityDiscontinuedFairValueHedgeCumulativeIncreaseDecrease
957000000 usd
CY2024Q1 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
770000000 usd
CY2024Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
767000000 usd
CY2024Q1 pfe Derivative Net Receivable Position Aggregate Fair Value
DerivativeNetReceivablePositionAggregateFairValue
251000000 usd
CY2024Q1 us-gaap Securities Received As Collateral
SecuritiesReceivedAsCollateral
274000000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3491000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3495000000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6273000000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5688000000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1128000000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1007000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
10892000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
10189000000 usd
CY2024Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
3361000000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
4568000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
104046000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
64147000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
39899000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
102944000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
62828000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40116000000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
22930000000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
22930000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
24784000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
24784000000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
126976000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
64147000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62829000000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
127728000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
62828000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
64900000000 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
109000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
67783000000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1524000000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-10000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
69297000000 usd
CY2024Q1 pfe Income Loss From Continuing Operations Available To Common Stockholdersdiluted
IncomeLossFromContinuingOperationsAvailableToCommonStockholdersdiluted
3120000000 usd
CY2024Q1 pfe Income Loss From Continuing Operations Available To Common Stockholders Basic
IncomeLossFromContinuingOperationsAvailableToCommonStockholdersBasic
3120000000 usd
CY2023Q2 pfe Income Loss From Continuing Operations Available To Common Stockholders Basic
IncomeLossFromContinuingOperationsAvailableToCommonStockholdersBasic
5542000000 usd
CY2023Q2 pfe Income Loss From Continuing Operations Available To Common Stockholdersdiluted
IncomeLossFromContinuingOperationsAvailableToCommonStockholdersdiluted
5542000000 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-5000000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3115000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3115000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5543000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5543000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5657000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5634000000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
40000000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
93000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5697000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5727000000 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26000000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
CY2024Q1 pfe Site Contingency Regulatory Proceedings Disclosure Threshold
SiteContingencyRegulatoryProceedingsDisclosureThreshold
1000000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 operatingsegment
CY2024Q1 us-gaap Assets
Assets
221000000000 usd
CY2023Q4 us-gaap Assets
Assets
227000000000 usd
CY2024Q1 us-gaap Revenues
Revenues
14879000000 usd
CY2023Q2 us-gaap Revenues
Revenues
18486000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3421000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6270000000 usd
CY2024Q1 us-gaap Revenues
Revenues
14879000000 usd
CY2023Q2 us-gaap Revenues
Revenues
18486000000 usd
CY2024Q1 pfe Percentage Change In Revenue
PercentageChangeInRevenue
-0.20
CY2024Q1 us-gaap Revenues
Revenues
14879000000 usd
CY2023Q2 us-gaap Revenues
Revenues
18486000000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000078003-24-000107-index-headers.html Edgar Link pending
0000078003-24-000107-index.html Edgar Link pending
0000078003-24-000107.txt Edgar Link pending
0000078003-24-000107-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pfe-20240331.htm Edgar Link pending
pfe-20240331.xsd Edgar Link pending
pfe-exh311x3312024x10q.htm Edgar Link pending
pfe-exh312x3312024x10q.htm Edgar Link pending
pfe-exh321x3312024x10q.htm Edgar Link pending
pfe-exh322x3312024x10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pfe-20240331_cal.xml Edgar Link unprocessable
pfe-20240331_def.xml Edgar Link unprocessable
pfe-20240331_lab.xml Edgar Link unprocessable
pfe-20240331_pre.xml Edgar Link unprocessable
pfe-20240331_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending